(Q42834541)

English

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes

scientific article published on November 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 November 2017

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes (English)

1 reference

Europe PubMed Central

8 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Scott A Summers

2

object named as

Scott A Summers

1 reference

Europe PubMed Central

8 November 2017

author name string

Jose Antonio Chavez

1

1 reference

Europe PubMed Central

8 November 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

8 November 2017

15 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592453

27 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0003986103004648?httpAccept=text/xml

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

https://api.elsevier.com/content/article/PII:S0003986103004648?httpAccept=text/plain

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Archives of Biochemistry and Biophysics

1 reference

Europe PubMed Central

8 November 2017

419

1 reference

Europe PubMed Central

8 November 2017

101-109

1 reference

Europe PubMed Central

8 November 2017

2

1 reference

Europe PubMed Central

8 November 2017

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

1

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

The metabolic syndrome X.

2

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply

3

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

4

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Signaling pathways mediating insulin-stimulated glucose transport

5

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Insulin signaling in the adipocyte

6

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

After insulin binds

7

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Insulin signalling: the role of insulin receptor substrate 1

8

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase

10

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action

11

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor

12

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

13

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Phosphatidylinositol 3-kinase

14

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

15

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond

16

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

PI3K: downstream AKTion blocks apoptosis

17

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide.

19

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells).

21

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Activation of protein kinase C alpha inhibits signaling by members of the insulin receptor family

22

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Protein kinase C modulates insulin action in human skeletal muscle

23

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Inhibition of insulin signaling and glycogen synthesis by phorbol dibutyrate in rat skeletal muscle

24

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Polyoma middle T antigen activates the Ser/Thr kinase Akt in a PI3-kinase-dependent manner

26

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism

27

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Characterization of free and glyceride-esterified long chain fatty acids in different skeletal muscle types of the rat

28

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Type of dietary fat and insulin resistance.

29

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Characterization of 3T3-L1 storage lipid metabolism: effect of somatotropin and insulin on specific pathways

30

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate

31

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Quantitative determination of ceramide using diglyceride kinase

32

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.

33

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Glucose and free fatty acid turnover in normal subjects and in diabetic patients before and after insulin treatment

34

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway

35

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression

36

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Diacylglycerol--when is it an intracellular messenger?

37

1 reference

10.1016/J.ABB.2003.08.020

https://api.crossref.org/works/10.1016/J.ABB.2003.08.020

27 March 2024

Identifiers

10.1016/J.ABB.2003.08.020

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42834541&oldid=2112096244"